Observational analysis shows EPI-4 reduced postharvest gray mold in peaches, suggesting enhanced antifungal properties of EPI analogues.
Epinecidin-1 (EPI), an antifungal peptide, has specific anti-Botrytis cinerea activity in vitro, but in vivo, it requires a very high concentration to efficiently manage postharvest gray mold. Our work aimed to improve the antifungal ability of EPI in vivo. A set of EPI analogues, generated by arginine substitution on the polar surface of EPI, was acquired. The biological properties of EPI and its derivatives were evaluated. Among the tested EPI analogues, the modified peptide EPI-4 demonstrated the most favorable characteristics, with higher anti-B. cinerea activity (the MIC value was 6 μmol/L compared to 12.5 μmol/L for EPI) and the lowest cytotoxicity. In vitro, EPI-4 disrupted the ultrastructure and cell membrane integrity of B. cinerea, induced more ROS accumulation, and enhanced the DNA binding ability of B. cinerea by twofold. More importantly, in vivo experiments confirmed that EPI-4 could effectively control postharvest gray mold of peach fruit at 50 μmol/L, and its control effect was significantly better than that of the template peptide EPI. Our findings suggest that EPI-4 demonstrates considerable promise as a valid compound for regulating gray mold disease in postharvest peaches.
No takes yet. Share an insight, caveat, or question.
Fan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: